Notice of Intent to Sole Source – Trilogy

This acquisition is for Red Hat Licenses, Services and Support for at the Department of Transfusion Medicine, Center for Cellular Engineering (CCE) at the National Institutes of Health (NIH) Clinical Center (CC). • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing • Place of Performance:

Bethesda, MD 20892 USA POTS:

25-009972 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Trilogy Innovations, located at 45 Professional Pl, STE 102, Bridgeport, WV, on a firm fixed price sole source award basis to provide Red Hat software licenses to the National Institutes of Health. Below is a description of the item(s):

Description: Red Hat OpenShift Kubernetes Engine, Premium, Confirmed Stateside Support (2 Cores, 4 vCPUs or 2 AI Accelerators), 1y Start Date:

10/01/2025 End Date:

09/30/2026 ACCT #:

6088283 Units:

Each Catalog: MW01016 Qty:

40 Description: Red Hat Enterprise Linux Server with Satellite, Premium 1y Start Date:

10/01/2025 End Date:

09/30/2026 ACCT #:

6088283 Units:

Each Catalog: RH00008 Qty:

6 Description:

Red Hat Consulting:

Senior Consultant, 1y Start Date:

10/01/2025 End Date:

09/30/2026 Units:

Hours Catalog: GPS-SC Qty: 20 This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.

Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by September 11, 2025 at 12pm EST.